ABCG2 and cancer: The inhibition of BCRP, MRP1, and P-gp proteins that pump chemotherapeutic drugs out of cells, reducing their effectiveness, leads to preventing the expelling of drugs from the cells, which can increase the intracellular concentration of chemotherapeutic agents, making these compounds more effective against resistant cancer cells.